Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -0.039\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] Cc1cc(C)n(-c2nc3c(c(=O)[nH]c(=O)n3C)n2CC(O)c2ccccc2)n1
[b] Cl.FC(F)(F)c1cccc(N2CCNCC2)c1
Answer: a. Cc1cc(C)n(-c2nc3c(c(=O)[nH]c(=O)n3C)n2CC(O)c2ccccc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)n(-c2nc3c(c(=O)[nH]c(=O)n3C)n2CC(O)c2ccccc2)n1
Cc1cc(C)n(-c2nc3c(c(=O)[nH]c(=O)n3C)n2CC(O)c2ccccc2)n1
8-(3,5-dimethylpyrazol-1-yl)-7-(2-hydroxy-2-phenylethyl)-3-methylpurine-2,6-dione